Q: What is your consensus of CTS earnings and outlook (after this mornings call)? Looks like a good quarter. If story is still intact, what do you see the range that stock might be in 12 months from now? Would you be a buyer?
What are your views on Altimmune (ALT-Q) and its growth prospects, its risks ? Would you buy it now for a growth account in a TFSA ? Which entry price would you suggest ?
Q: Peter and His Wonder Team
They just reported what appear to be good results. Please give me your opinion especially in regards to 2024. Is there anything that looks like a "red-flag"? Thanks as usual...
Q: Can you comment on todays news of takeover of Spirent and what it can mean going forward. Market seems to like it. What's your take? Is it a good buy?
Q: Would you suggest an ETF for US-Midcap only (in $USD and/or $CDN).
I already have VB for SmallCap, TDB3093 for MidCap, SPY and QQQ. Too much overlap? Thanks.
Q: Hello! I currently have enough funds to invest in a single stock within my TFSA. I’m considering two options: LMN and HPS.A. Could you please provide your insights on which one I should purchase first? Additionally, I’m curious about their growth potential in the future. Are either of these stocks considered potential “10-baggers”? Your guidance would be greatly appreciated. Thank you! 🌟
Q: My question today on price points for buying and selling LMN in my TFSA is derived from my experience with the ups and downs of EGLX which I rode from $1.90 to $11.00 to $.90 at which point I dumped it. I have LMN in my TFSA and it will be a long term hold. I am looking at GLXY and don’t want to repeat the EGLX story. Like EGLX , GLXY is in a “ happening “ sector with
well thought of management, a Canadian small cap expected to list on the NASDAQ. You had EGLX in the growth portfolio; recommended it at $7.00 but then eventually sold it. You saw a reason to sell that I didn’t and I paid the price. What am I to look at specifically for GLXY so I don’t repeat the same mistake ? ( Maybe I should just stay away with stocks that have the letters LXY in their ticker ! )
Thanks. Derek
Q: Someone at 5i has held IAS in the past, and with the sudden drop last week, I was wondering if it was still a holding? Analysts still seem to like the company, do you still like its prospects? I asked this question last week, but have not received a response.
Matthew
Can you review the LMN results and provide your feedback on the results. Also can you comment on valuation EV/Ebitda and its growth rate relative to expectations.
Q: This company if you takeaway the pandemic crash is at 5 year low,would you consider this a good entry point and also how safe is the dividend for a 1-2 year hold do you think it can get back to $1.20-1.40 range…Thanks
Q: Hi Peter & 5i,
Would you please give your asessment of TCS' 3rd quarter.
Just started looking at this company from your last growth portfolio update. Would you be able to give what their historical Annual Renewal Rate (ARR) % has been on their contract subscriptions?
Thanks for your always great advice and information.
Q: I am investigating CLS as a potential long term investment. In a recent answer to a question, 5i stated that CLS seems to be putting things together much better now. What is CLS putting together much better now, and is it sustainable? How important is AI, to CLS future share price? Could you elaborate on the most major risk to CLS share price? Would you consider CLS a good hold for five plus years?? Thanks for the excellent analysis!